Bremer Bank National Association’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,789
Closed -$1.2M 189
2020
Q1
$1.2M Buy
3,789
+25
+0.7% +$7.59K 0.34% 77
2019
Q4
$1.12M Buy
3,764
+14
+0.4% +$3.88K 0.24% 101
2019
Q3
$873K Sell
3,750
-426
-10% -$99.2K 0.19% 112
2019
Q2
$977K Buy
4,176
+44
+1% +$10.2K 0.21% 111
2019
Q1
$947K Buy
+4,132
New +$1.3M 0.19% 119

Other funds holding BIIB

Bremer Bank National Association's BIIB Position: Q2 2020 in Review

Bremer Bank National Association sold out of Biogen (BIIB) in Q2 2020, closing a stake of 3,789 shares — an estimated $1.2M sold.

Bremer Bank National Association first reported a position in BIIB in Q1 2019 and held it in 5 quarters. The position peaked at $1.2M in Q1 2020. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Bremer Bank National Association reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Bremer Bank National Association sold 3,789 Biogen shares in Q2 2020, an estimated $1.2M.
  • Bremer Bank National Association first reported a position in Biogen in Q1 2019 and held it in 5 quarters.
  • Bremer Bank National Association's Biogen position peaked at $1.2M in Q1 2020.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Bremer Bank National Association's 13F filing for Q2 2020, filed 28 Jul 2020.